TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM. November 5, 2004
TCL Archive In Brief: Mauer New AACI President, Steckel Named President-Elect; Prevention Conference Set January 25, 1980
TCL Archive New Breast Cancer Therapies Move Into General Practice; Fisher, Miami Plan Segmental Trials February 13, 1976
TCL Archive “Long Overdue” Efforts By States Urged To Help Fund Community, Regional Cancer Control Efforts August 4, 1978
